Heart Disease News and Research

Latest Heart Disease News and Research

Machine learning algorithms help predict out-of-hospital cardiac arrest survival

Using neighborhood and local data in combination with existing information sources creates a more accurate prediction on a patient's recovery prospects after an out-of-hospital cardiac arrest (OHCA), according to preliminary research to be presented at the American Heart Association's Resuscitation Science Symposium 2020.

9 Nov 2020

Serious health inequities exist for racial and ethnic minorities with heart problems

Adults from underrepresented racial groups who have acute heart blockages and cardiac arrests received fewer early interventions, had longer hospital stays and higher death rates than their white counterparts, according to preliminary research to be presented at the American Heart Association's Resuscitation Science Symposium 2020.

9 Nov 2020

Study reveals link between food insecurity and increased risk of cardiovascular death

Food insecurity is one of the nation's leading health and nutrition issues--about 13.7 million (10.5 percent) of households in the United States were food insecure at some time during 2019, a trend likely to increase in light of the COVID-19 pandemic.

9 Nov 2020

Centhaquine drug improves outcomes, reduces death rate in patients with severe blood or fluid loss

Centhaquine, a new medication to treat patients who have severe blood or fluid loss, significantly improved outcomes and reduced death rate when added to standard of care, compared to standard care alone, according to preliminary research to be presented at the American Heart Association's Resuscitation Science Symposium 2020.

9 Nov 2020

Exposure to higher ozone concentrations is linked to higher risk of cardiac arrest

Exposure to higher ozone concentrations in the air is significantly associated with a higher risk of out-of-hospital cardiac arrest (OHCA), according to preliminary research to be presented at the American Heart Association's Resuscitation Science Symposium 2020.

9 Nov 2020

ResMed launches new sleep education campaign

ResMed, a global leader in digital health and connected sleep and respiratory care devices, today announced the launch of a new sleep education campaign, #WakeUpToGoodSleep.

9 Nov 2020

New Independent Research Organization status awarded to Anthony Nolan and ANRI

Anthony Nolan and the Anthony Nolan Research Institute have a long tradition of supporting and engaging with researchers.

9 Nov 2020

Study: Hydroxychloroquine has no effect on abnormal heart rhythm in lupus patients with CKD

New research shows that adults with lupus who take the antimalarial drug, hydroxychloroquine, do not have any differences in their corrected QT (QTc) intervals, an electrocardiogram (EKG) measurement of the heart's electrical signals, even if they have chronic kidney disease (CKD), a complication of lupus that can be associated with increased levels of the medication.

9 Nov 2020

New model aims to predict risk of cardiovascular disease in people with type 2 diabetes

Researchers from the University of Sydney’s School of Project Management within the Faculty of Engineering have developed a model which aims to predict the risk of people living with type 2 diabetes developing cardiovascular disease.

9 Nov 2020

National Covid-19 Resilience Programme in the UK would support older people through pandemic

Public health agencies across the UK should launch a National Covid-19 Resilience Programme to support older people through the pandemic and to keep them healthy and resilient over the winter - that's the recommendation from a leading group of scientists and clinicians working in the fields of physiology, nutrition and physiotherapy.

9 Nov 2020

Researchers identify new strategy to combat loss of skeletal muscle mass

Researchers at the University of São Paulo (USP) in Brazil have shown for the first time that stimulating expression of a protein naturally produced by the human body can be a strategy to combat loss of skeletal muscle mass, which happens normally with aging but can intensify in cases of neurodegenerative or inflammatory disease, or in patients who spend long periods in intensive care units (ICUs).

9 Nov 2020

Air pollution accounts for premature deaths from cardiovascular disease

In a current opinion article "Reduction of environmental pollutants for prevention of cardiovascular disease: it's time to act", published in the European Heart Journal this week.

9 Nov 2020

Pre-existing antibodies created during COVID-19 may protect children against new pandemic strain

Researchers at the Francis Crick Institute and University College London have found that some antibodies, created by the immune system during infection with common cold coronaviruses, can also target SARS-CoV-2 and may confer a degree of protection against the new viral strain.

9 Nov 2020

Study shows SARS-CoV-2 direct heart muscle cell infection, cell death, loss of contractility

In the study, published on the pre-print journal bioRxiv, the researchers revealed that SARS-CoV-2-infected EHTs manifested the typical characteristics of myocarditis or heart inflammation. These include the stimulation of immune cells, heart cell death, and decreased contractile force generation.

8 Nov 2020

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

Today, the U.S. Food and Drug Administration permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD).

8 Nov 2020

Children with Kawasaki Disease at increased risk for cardiovascular events 10 years later

New research shows that children with Kawasaki Disease remain at an increased risk for cardiovascular events more than 10 years after hospitalization for their condition, highlighting the need for long-term heart disease surveillance and risk reduction strategies for these young patients.

6 Nov 2020

Black patients with lupus have higher risk of stroke and ischemic heart disease

New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease.

6 Nov 2020

Virginia Tech student receives NSERC award to develop minimally invasive treatment for glioblastoma

The Natural Sciences and Engineering Research Council of Canada (NSERC) supports research that results in "breakthrough answers to timeless questions." When choosing awardees, the council looks for creativity and innovation, two qualities they see at the heart of all research advances.

6 Nov 2020

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

New research shows that adults with systemic lupus erythematosus, who receive trimethoprim-sulfamethoxazole (TMP-SMX), a prophylactic therapy to help prevent pneumocystis pneumonia, are at high risk for adverse reactions to the drug, particularly if they are also positive for anti-Smith (anti-Sm) antibodies.

6 Nov 2020

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

A new study shows that patients with rheumatic diseases across Africa, Southeast Asia, the Americas and Europe had trouble filling their prescriptions of antimalarial drugs, including hydroxychloroquine, during the 2020 global coronavirus pandemic, when antimalarials were touted as a possible COVID-19 treatment.

6 Nov 2020

Heart Disease News and Research

Latest Heart Disease News and Research

Machine learning algorithms help predict out-of-hospital cardiac arrest survival

Serious health inequities exist for racial and ethnic minorities with heart problems

Study reveals link between food insecurity and increased risk of cardiovascular death

Centhaquine drug improves outcomes, reduces death rate in patients with severe blood or fluid loss

Exposure to higher ozone concentrations is linked to higher risk of cardiac arrest

ResMed launches new sleep education campaign

New Independent Research Organization status awarded to Anthony Nolan and ANRI

Study: Hydroxychloroquine has no effect on abnormal heart rhythm in lupus patients with CKD

New model aims to predict risk of cardiovascular disease in people with type 2 diabetes

National Covid-19 Resilience Programme in the UK would support older people through pandemic

Researchers identify new strategy to combat loss of skeletal muscle mass

Air pollution accounts for premature deaths from cardiovascular disease

Pre-existing antibodies created during COVID-19 may protect children against new pandemic strain

Study shows SARS-CoV-2 direct heart muscle cell infection, cell death, loss of contractility

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

Children with Kawasaki Disease at increased risk for cardiovascular events 10 years later

Black patients with lupus have higher risk of stroke and ischemic heart disease

Virginia Tech student receives NSERC award to develop minimally invasive treatment for glioblastoma

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in